Ann: Change of Director and Company Secretary, page-23

looks like it has bounced off low nicely thats a real test as agreed it would have gone lower.
As mentioned it is just a NED role, non operational and really isn't going to impact SP. Already at low's which have been consolidating for some time.... shows possible instability; however, the company is early stages of growth coming out of Long term R&D.

I feel last quarter was especially crap but can move from here...Who knows... there are multiple companies with valuations well exceeding realised revenue especially in global markets the size in which HCT plays.... again just takes a couple of solid contracts, ann's for a re-rate and that is the punt,.